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Rationale: Methylated amino compounds and basic amino acids are important
analyte classes with high relevance in nutrition, physical activity and physiology.
Reliable and easy quantification methods covering a variety of metabolites in body
fluids are a prerequisite for efficient investigations in the field of food and nutrition.
Methods: Targeted ultra-performance liquid chromatography/tandem mass
spectrometric (UHPLC/MS) analysis was performed using HILIC separation and
timed ESI-MRM detection, combined with a short sample preparation. Calibration in
urine and blood plasma was achieved by matrix-matched standards, isotope-labelled
internal standards and standard addition. The method was fully validated and the
performance was evaluated using a subset from the Karlsruhe Metabolomics and
Nutrition (KarMeN) study.
Results: Within this method, a total of 30 compounds could be quantified
simultaneously in a short run of 9 min in both body fluids. This covers a variety of
free amino compounds which are present in very different concentrations. The
method is easy, precise and robust, and has a broad working range. As a proof of
principle, literature-based associations of certain metabolites with dietary intake of
respective foods were clearly confirmed in the KarMeN subset.
Conclusions: Overall, the method turned out to be well suited for application in
nutrition studies, as shown for the example of food intake biomarkers in KarMeN.
Application to a variety of questions such as food-related effects or physical activity
will support future studies in the context of nutrition and health.
1 | INTRODUCTION
Accurate and specific quantification of metabolites in body fluids is a
key prerequisite for studies investigating for example the nutritional
and physiological aspects of food consumption as well as physical
activity. Besides emerging untargeted metabolomic approaches1-3
there is still an urgent need for reliable targeted approaches with
focus on specific compounds or compound classes. For instance,
compounds with low mass and high polarity, such as methylated
amino compounds, may not always be covered by generalized
metabolite profiling methods. One approach to overcome poor
retention in conventional reversed-phase (RP) chromatography is the
use of hydrophilic interaction chromatography (HILIC) for targeted
multi-component liquid chromatography/mass spectrometry (LC/MS)
analysis.4,5
Several methylamines were found to be associated with the
consumption of specific foods, including trigonelline for coffee,6
stachydrine (proline-betaine) for citrus fruits7, trimethylamine-N-oxide
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(TMAO) for fish,8-12 or histidine-containing compounds (N-
methylhistidine isomers, dipeptides anserine and carnosine) for
meat.11,13-17 In the context of physical activity, it has been
reported that certain compounds are increased after heavy exercise,
such as β-aminoisobutyric acid,18 or correlate inversely with fitness
(e.g. asymmetric N,N-dimethylarginine, ADMA).19 It is also known
from epidemiological studies that specific methylated amines are
associated with the risk for cardiovascular diseases, for instance
ADMA20,21 or TMAO.22-25 TMAO is also a striking example of the
recently recognized importance of the gut microbiota for food-
related health issues.26,27 In summary, this compound class is of
high relevance and an interesting target for all studies related to
nutrition, physical activity, and health.
A variety of methods for targeted amine analysis has been
reported, mostly applying LC/MS. For instance, the analysis of
betaines was described previously, e.g. fruit-derived proline-
betaines.7,28 Glycine-betaine is often analyzed in combination with
other nitrogen-containing compounds such as choline, N,N-
dimethylglycine (DMG), trimethylamine (TMA) or TMAO.29-34
Quantification of methylated arginine compounds such as ADMA is
established in a clinical context.35-38 Dipeptides and methylhistidines
were described recently as putative markers of meat intake.13-15,39-41
However, methods integrating a high number of these compounds
into one validated quantitative method are scarce.
Here, we report the evaluation and validation of an easy and
robust quantitative ultra-performance liquid chromatography/tandem
mass spectrometric (UPLC/MS/MS) method covering 30 methylated
amines and basic amino acids present in human urine and blood
plasma. Suitability for the method was proved by analyzing a subset
of urine samples from the Karlsruhe Metabolomics and Nutrition
(KarMeN) study.42 Based on the above-mentioned literature, we
choose the food groups coffee, citrus fruits, and meat for a proof of
principle for the quantified metabolites. The validated method enables
reliable quantification of methylated amines and is currently being
applied in several human studies.
2 | EXPERIMENTAL
2.1 | Materials and standards
Acetonitrile (LCMS grade) was obtained from VWR (Darmstadt,
Germany). Ammonium formate (HPLC grade) and formic acid (LC/MS
grade) and most amine standards were from Sigma-Aldrich (Steinheim,
Germany). Deuterated internal standards (ISTDs) were either from Euriso-
Top (Saarbrücken, Germany), EQ Laboratories (Augsburg, Germany) or
TRC (Toronto, Canada), supplied by Biozol (Eching, Germany).
2.2 | LC/MS instrumentation and method
For compound quantification, an Acquity UPLC H-Class system
coupled to a Xevo TQD triple quadrupole mass spectrometer (Waters,
Eschborn, Germany) was used. A previously described HILIC/ESI-
MRM method comprising six methylated amines33,34,43 was extended
to cover 30 amine compounds in one short run, and was adapted to
the body fluids, urine and blood plasma.
A polar HILIC column (Acquity BEH Amide, Waters) with the
following dimensions was used for separation: 100 × 2.1 mm, 1.7 μm
particle size. The column oven was maintained at 30C and the
autosampler at 12C. The injection volume was 1 μL at a flow rate of
0.6 mL/min using a solvent delay of 1 min. Eluent A was a 1:1 mixture
of acetonitrile and aqueous 50 mM ammonium formate, which was
adjusted to pH 3.2 with formic acid (FA). Eluent B was acetonitrile
with 0.05% FA. The following inverse acetonitrile gradient was
used: from initial 12% A to 51.5% A in 3 min, then isocratic until
4 min, then to 85% A at 5.9 min, and back to 12% A. The duty cycle
was 9 min.
Mass spectrometric detection was performed with electrospray
ionization (ESI) in positive ion mode using a capillary voltage of
2.0 kV. The desolvation temperature and gas flow rate were set to
500C and 1000 L/h. The source temperature and cone gas flow rate
were 150C and 50 L/h. Analyte-specific quantification was
performed by multiple reaction monitoring (MRM) with time windows
and two transitions per analyte, where possible. Isotope-labelled
compounds were used as internal standards. Details of the MRM
method are provided in Table 1. TargetLynx (Waters) and Microsoft
Excel were used for data processing using the Apex Track algorithm
for peak integration. Peaks were smoothed by mean (1–2 times,
smoothing width 2) and the calibration was quadratic without
weighting.
2.3 | Sample preparation and matrix calibration
Stock solutions of standards and their isotope-labelled counterparts
were prepared at 1 mg/mL in 50% acetonitrile, and 90% acetonitrile
was used for further dilution. The analytes were sorted into four
groups with different calibration range, adapted to the expected
concentration range in the respective matrix. Samples were prepared
by protein precipitation and dilution with eluent A, either by a factor
1:10 for plasma or a factor 1:25 for urine. The ISTD-mixture
contained 17 compounds (dimethylamine (DMA)-d6, TMAO-d9,
sarcosine-d3, α-aminoisobutyric acid-d3, DMG-d6, choline-d9,
creatinine-d3, betaine-d3, proline-d7, creatine-d3, trigonelline-d3,
histidine-13C6, carnitine-d9, π-methylhistidine-d3, citrulline-d7,
arginine-13C6-15N4, ADMA-d6) at three different levels (50/100,
250 or 500 μM depending on the calibration range of the respective
compound) and was spiked directly to the precipitation solution.
Matrix-matched calibrators (6 levels) and controls (3 levels) were
prepared by adding 10 μL of each of the four analyte mixtures with
different concentration range directly to the human matrix sample,
and subsequent dilution as described above. Aliquots of the identical
sample were used as calibrators and controls and spiked accordingly.
Standard addition was performed to quantify the original analyte
concentrations of this specific matrix sample. This calculation was
performed for each analysis sequence to account for variations in
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TABLE 1 Compound table for urine and plasma analysis







1 2 1 2 Urine Plasma
[min] # [m/z] [m/z] [m/z] 2/1 [V] [eV] [eV] # #
1 Dimethylamine 1.74 2 46.0 30.0 31.0 0.83 45 30 28 B C
2 Dimethylamine-d6 1.76 n.d. 52.1 34.0 45 30 I2 I3
3 Trimethylamine 1.59 2 60.0 44.0 45.0 1.14 40 20 16 D C
4 TMAO 1.51 5 76.0 58.1 59.1 0.98 35 15 15 A C
5 TMAO-d9 1.53 n.d. 85.1 68.1 15 15 I1 I3
6 Sarcosine 3.29 7 90.0 44.0 18 10 C D
7 Sarcosine-d3 3.29 n.d. 93.0 47.1 18 10 I3 I3
8 N,N-Dimethylglycine 2.92 14 104.0 58.1 28 12 C C
9 α-Aminobutyric acid 3.20 13 104.0 58.0 20 10 D B
10 Choline 1.59 15 104.0 44.9 60.0 1.75 42 16 16 C C
11 β-Aminoisobutyric acid 2.71 13 104.1 30.1 86.0 0.92 32 10 10 C C
12 γ-Aminobutyric acid 2.63 13 104.2 69.1 87.0 8.42 25 11 11 D D
13 β-Aminoisobutyric acid-d3 2.76 n.d. 107.1 29.9 32 10 I2 I2
14 Dimethylglycine-d6 2.94 n.d. 110.0 64.1 28 12 I3 I3
15 Choline-d9 1.58 n.d. 113.1 69.1 42 16 I3 I3
16 Creatinine* 1.50 18 114.1 44.1 86.1 5.50 40 12 12 None* A
17 Proline 3.00 21 116.0 70.2 32 13 C A
18 Creatinine-d3* 1.49 n.d. 117.0 47.0 40 12 None* I1
19 Betaine 2.60 20 118.0 58.1 59.1 2.92 38 16 16 C B
20 Betaine-d3 2.62 n.d. 121.0 62.2 38 16 I3 I2
21 Proline-d7 3.02 n.d. 122.9 76.9 32 13 I3 I1
22 N-Methylproline 2.66 21 130.2 84.1 32 14 D B
23 Hydroxyproline 3.52 21 132.1 67.9 86.1 1.94 40 16 14 C B
24 Creatine 3.16 25 132.2 44.2 90.1 1.01 32 18 14 B B
25 Creatine-d3 3.19 n.d. 135.1 92.9 32 14 I2 I2
26 Trigonelline 2.78 27 138.2 78.0 92.1 2.93 32 26 24 B D
27 Trigonelline-d3 2.79 n.d. 141.1 97.0 32 24 I2 I3
28 Stachydrine 2.57 27 144.1 58.1 84.0 0.79 40 24 20 B D
29 γ-Butyrobetaine 1.92 36 146.1 60.0 87.1 1.57 45 12 16 D C
30 Histidine 4.64 32 156.0 94.8 109.9 15.48 25 14 12 A A
31 Betonicine 2.94 27 160.1 58.1 40 24 D D
32 Histidine-13C6 4.65 n.d. 162.0 115.0 33 I1 I1
33 Carnitine 2.41 36 162.0 60.0 102.8 1.13 36 16 16 B B
34 π-Methylhistidine 4.60 37 170.1 95.9 108.9 1.11 32 14 14 B B
35 τ-Methylhistidine 4.26 37 170.1 108.9 124.2 4.45 32 14 14 B C
36 Carnitine-d9 2.41 n.d. 171.1 102.8 36 16 I2 I2
37 τ-Methylhistidine-d3 4.27 n.d. 173.0 127.2 32 14 I2 I2
38 Arginine 4.60 41 175.1 70.0 115.9 0.34 32 18 14 C A
39 Citrulline 4.06 40 176.2 70.0 112.9 0.58 20 16 12 C B
40 Citrulline-d7 4.06 n.d. 183.0 120.1 20 12 I2 I2
41 Arginine-13C6-15N4 4.62 n.d. 185.1 75.1 32 14 I3 I2
42 N-Methylarginine 4.28 41 189.2 70.1 116.2 0.27 32 19 15 D C
43 ADMA 4.13 45 203.0 88.1 116.1 0.91 32 16 14 B D
(Continues)
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sample preparation and instrument response. With this information, a
second data processing run was performed, now using the real
concentrations of the calibrators (matrix background + spike). These
calibration curves were then used for subsequent quantification of
unknown samples.
2.4 | Method evaluation
Precision and accuracy (bias with respect to the calculated value)
were tested using spiked matrix samples as described in section 2.3
(3 levels, each n = 3). Within-day precision was determined batch-
wise (n = 12), and controls of regular sample sequences were used to
determine day-to-day precision.
The recovery and matrix effect were estimated in one experiment
(2 levels, each n = 3; ISTDs 1 level, n = 3). Matrix samples were either
spiked before or after sample preparation to calculate recoveries.
These matrix samples were run together with matrix-free standards of
identical nominal concentration to calculate matrix effects. Thus,
matrix effects were determined by comparing normal LC/MS runs
with and without matrix, rather than by infusion experiments. The
recovery and matrix effects were determined for standards and
internal standards separately at different concentrations. In the case
of non-labelled standards, a matrix blank was used for background
subtraction.
Since analyte-free samples were not accessible, working ranges
were assessed by using surrogate matrices and subsequent dilutions
(n = 3). The surrogate urine matrix was prepared as follows: 20 mM
ammonium formate, 208 mM urea, 1.5 mM ureic acid, 25 mM
potassium hydrogen phosphate and 75 mM sodium chloride.44
Surrogate blood plasma was prepared by dissolving 7% bovine
serum albumin in PBS buffer. Lower limits of quantification (LLOQs)
and limits of detection (LODs) were also estimated from these
linearity experiments using the following criteria: LLOQ: signal-to-
noise ration (S/N) >10, coefficient of variance (CV) <30%, deviation
from linear regression curve <30%; LOD: S/N >3. The sum of matrix
background plus highest spike (= real concentration of highest
matrix calibrator) was defined as the upper limit of quantification
(ULOQ).
Stability was determined by storing control samples (3 levels,
n = 3 each) at various conditions. The following storage conditions
were tested: 2 months at −20C, 1 week at 6–8C, 6 h at room
temperature (RT), and after 3 freeze–thaw cycles (−20C and RT).
2.5 | Human study samples
A detailed description of the KarMeN study can be found
elsewhere.42 The study is registered at the German Clinical Trials
Register (number DRKS00004890). Briefly, 301 female and male
participants from age 18 to 80 were included. The aim of the study
was to investigate associations of the human metabolome (plasma/
serum and urine) with age, sex, diet, body composition and physical
activity. During the study, numerous parameters were assessed, for
instance current food consumption, body composition, medical
history, physical activity and cardiorespiratory fitness. Several urine
and one blood samples were collected at the study center and
analyzed by clinical biochemistry and a variety of metabolomics
methods, including 1H-NMR, LC/MS and GC×GC/MS.43 Kidney
function was estimated by measuring glomerular filtration rate (GFR,
mL/min/1.73 m2) based on 24-h urine creatinine clearance. Urinary
metabolite excretion was expressed in mmol/24 h.
2.6 | Dietary assessment
Trained study personnel assessed the food intake of each individual
(in g/day) in a personal interview using a 24-h dietary recall with the
software EPIC-Soft.45,46 Participants used standard units (such as slice
of bread, soup bowl), household measurements (such as tablespoon)
and a picture booklet providing photographs of portion sizes for
various foods to indicate the consumed amount per meal. Based on
TABLE 1 (Continued)







1 2 1 2 Urine Plasma
[min] # [m/z] [m/z] [m/z] 2/1 [V] [eV] [eV] # #
44 SDMA 4.08 45 203.0 88.1 116.1 2.48 32 16 14 B D
45 ADMA-d6 4.09 n.d. 209.2 94.2 32 14 I2 I3
46 Carnosine 4.72 32 227.1 110.0 156.1 0.51 32 14 16 C D
47 Anserine 4.67 32 241.1 109.0 170.1 0.42 40 18 16 B D
*Quantified in plasma only, intensity in urine too high.
§Spike range/maximum spike of calibration standards [μM]: Urine: 5000 (A), 1000 (B), 200 (C), 40 (D); Plasma = 500 (A), 200 (B), 100 (C), 40 (D); Internal
STD: 50/100 (I1), 250 (I2), 500 (I3).
Time windows were at least 0.7 min per compound. Dwell times were calculated automatically by the instrument software using the following conditions:
peak width 4 s; required points per peak 12. Both transitions were used for calculation of quantitative values, if applicable.
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the literature, we selected a subset of 69 participants from this study
group with either a high consumption of coffee, citrus fruits, fish and
seafood, or total meat (including sausages and meat products), also
stratified into white and red meat11,13-17 or a negligible consumption
of the respective foods. Thus, a comparison of metabolite
concentrations between consumers and non-consumers or high and
low consumption, respectively, could be performed for selected
foods. General characteristics and dietary intake of the KarMeN
subset are given in File S1, supporting information.
2.7 | Statistical evaluation
As a proof of principle, partial Spearman correlation analysis adjusted
for GFR was used to investigate the associations between urinary
metabolite concentrations and the food groups of interest. All
statistical analyses were performed using SAS software version 9.4
(SAS Institute, Cary, NC, USA) with p-values <0.05 considered as
statistically significant. To correct for multiple testing, the false
discovery rate (FDR) was controlled at 0.05 using the Benjamini-
Hochberg method.47
3 | RESULTS AND DISCUSSION
3.1 | Method development
In a first step, more than 40 amino compounds of interest in the
context of nutrition and physiology were chosen and tested for
possible integration into the new method. Non-methylated and
partially N-methylated analogues of fully N-methylated amines were
included wherever possible, e.g. in the case of the amino acids
(hydroxy)proline, histidine or arginine. Moreover, aminobutyric acids
were included as interesting targets with similar properties (e.
g. polarity, basicity). Electrospray source conditions as well as
fragmentation parameters were optimized by syringe infusion and a
short, previously established acetonitrile gradient on the HILIC
column.33,34,43 Most compounds showed strong ESI signals and
efficient fragmentation. However, a few compounds gave low
signal intensity and/or were not stable under the selected HILIC
conditions without derivatization, for instance phosphorylated
compounds (phosphocholine, phosphocreatine), polyamines
(putrescine, spermine), ornithine and taurine. However, none of the
affected analytes was essential for our studies, and the goal was to
make the method as easy as possible. In the end, a panel of about
30 analytes with the highest priority was selected. In principle, this
panel could be further extended, since a number of additional
analytes with good sensitivity was identified, including acetylcarnitine
(as an example of the acylcarnitines), spermidine (as an example for
amines) and additional amino acids such as valine, serine or
tryptophane. A list of included analytes is available in Table 1.
Two MRM transitions were applied wherever possible and
optimized, except for the few compounds which showed only one
intense product ion. Both transitions were used for quantification in
order to maximize peak intensities. Nevertheless, transition intensity
ratios (see Table 1) may still be used to monitor peak purity and to
account for possible interferences, as in the classical quantifier/
qualifier approach. Therefore, we have investigated ratio variance in
urine and plasma and compared it with ratios in pure standards.
Overall, we found consistent intensity ratios, irrespective of matrix or
concentration. The ratio variation was usually below 15%, and often
below 5%. Only a few compounds showed higher ratio variance
especially at very low concentrations (e.g. hydroxyproline, γ-
aminobutyric acid, TMA, anserine), pointing to minor interferences for
those compounds.
Since we had also isomers and compounds with identical
precursor mass and very similar fragmentation, the gradient had to
be optimized to separate critical pairs, for instance the
methylhistidines (m/z 170), the aminobutyric acids and
dimethylglycine (m/z 104), and the dimethylarginines (m/z 203).
Resulting separations using the final gradient are shown in
Figure 1 and File S2, supporting information.
It is known that for HILIC somewhat longer equilibration times
are necessary than for RP chromatography. However, we found that
2.5 min equilibration time was sufficient to guarantee stable retention
times for the next injection, leading to a total duty cycle of 9 min
between two injections. Based on this final gradient, an MRM method
with time windows was established, in order to optimize detection
efficiency. The parameters were set to give at least 12 points per
peak with 4 s peak width, leading to dwell times between 8 and
12 ms.
In the next step, we tested the influence of the matrix (urine,
plasma) on analytical performance. Samples were diluted with organic
solvent, which eventually leads to protein precipitation especially in
the case of plasma samples. After centrifugation, samples could be
directly injected without the need for further sample cleanup.
However, it turned out that it was crucial to dissolve the samples in a
solvent resembling the starting conditions of the gradient as closely as
possible to maintain stable retention times and peak shape. The effect
was more pronounced in the case of urine, obviously caused by the
higher salt content and pH variations. In contrast, plasma matrix is
always quite similar and its pH is highly regulated.
In further experiments, possible interferences from matrix as
well from concomitant standard compounds were tested, including
the isotope-labelled internal standards. No severe interferences
were found at the respective retention times of the analytes. For
internal calibration, up to 16 isotope-labelled standards were used.
However, isotope-labelled analogues were lacking for about half
the analytes, which may limit accuracy and specificity for these
compounds. To minimize inaccuracy as far as possible, each analyte
was assigned to a surrogate ISTD with close structural similarity
and retention time. Different dilution factors were used depending
on the matrix, a factor 25 for urine and a factor 10 for plasma.
Moreover, analytes were sorted into four groups with different
calibration ranges, depending on the expected concentrations and
the matrix: urine or plasma.
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3.2 | Method validation
A summary of the validation data is shown in File S3, supporting
information.
Precision and accuracy were tested batch-wise and in series using
spiked control samples. For some analytes, values for the lowest
control were below the LLOQ; consequently, these were not
considered for validation. Generally, the precision was good with CV
<8% for most analytes, in many cases <5%. Only a few analytes had
CV >15%, primarily in the very low concentration range, e.g. citrulline,
N-methylarginine or the butyric acids (urine), or choline, β-
aminoisobutyric acid, betonicine and DMA (plasma). Accuracy was
checked by analyzing the bias versus a calculated reference value,
including the amount present in the sample before spiking. Since the
latter had to be estimated from standard addition, this reference can
only be an approximation to the true value. Consequently, no
accuracy values are provided for the lowest control samples, since for
those the calculation error for any reference value would be in the
same order as the analytical error. Nevertheless, the bias of higher
levels was small and did not exceed 15% in the case of urine, except
for a few analytes with slightly higher bias in the low concentration
range, e.g. the dimethylarginines, N-methylproline or the butyric acids.
The observed deviations may be in part artificial and are probably
related to the applied background subtraction procedure, since no
bias >10% was observed for isotope-labelled compounds, for which
no background subtraction was necessary. Moreover, a recent
method comparison with 1H-NMR demonstrated excellent correlation
in urine, with R2 >0.87 for those compounds which were accessible
with both methods.48 For plasma, the estimated accuracy was as good
as for urine, at least for the majority of compounds. However, some
compounds showed a somewhat lower accuracy, especially those
with histidine or arginine moieties. Probably this was due to a certain
plasma protein binding, reflected also by comparably low recoveries
(see below). Note that precision for these compounds was still quite
high and not compromised.
Most LLOQs were in the low μM range, depending on the
calibration range applied. The method has a broad working range, the
factor between LLOQ and ULOQ was between 20 and >400,
depending on the compound. This is important to cover the expected
large variations, for instance after current food consumption. Taking
into account S/N only, the covered concentration range is even
higher, at least a factor 100 and up to four orders of magnitude for a
number of compounds. LOD values (S/N 3:1) are mostly in the nM
range.
In the case of urine, the recovery was excellent with values
between 71 and 109%. The matrix effects were a bit more
pronounced; however, the signal intensities of spiked matrix samples
were still within 75 and 125% of those of the matrix-free standards
for most compounds. Matrix suppression with signal intensities <75%
was the exception, e.g. in the case of citrulline or N-methylarginine.
Moreover, matrix enhancement up to 163% was observed for very
few compounds, e.g. N-methylproline or TMA. These results are in
accordance with the simple sample preparation protocol: without
extensive purification, analyte losses are unlikely, whereas matrix
compounds are still present and may compromise sensitivity.
However, validation data show clearly that both analyte loss and
matrix effects are in a tolerable range and do not compromise the
performance of the method. In plasma, the effects of recovery and
matrix were a bit more pronounced than in urine, but still tolerable
and efficiently compensated for by ISTD addition. Matrix suppression
up to 60% was observed for very few compounds only, e.g. for β-
aminoisobutyric acid or trigonelline. Matrix enhancement up to 70%
was found e.g. for τ-N-methylhistidine, ADMA or sarcosine. In
principle, good recoveries were also obtained, similar to urine.
F IGURE 1 LC/MS chromatograms of spiked matrix samples; left panel: Urine*; right panel: Blood plasma (*note: urine without creatinine
spike, to avoid peak saturation). α-AB = α-aminobutyric acid; β-AiB = β-aminoisobutyric acid; γ-AB = γ-aminobutyric acid; γ-BB = γ-butyrobetaine;
π-MeHis = π-methylhistidine; τ-MeHis = τ-methylhistidine; ADMA = asymmetric dimethylarginine; Anser = anserine; Arg = arginine;
Carnos = carnosine; Citr = citrulline; DMA = dimethylamine; DMG = N,N-dimethylglycine; His = histidine; HyPro = hydroxyproline; MeArg = N-
methylarginine; MePro = N-methylproline; Pro = proline; Sarc = sarcosine; SDMA = symmetric dimethylarginine; TMA = trimethylamine;
TMAO = trimethylamine-N-oxide; Trig = trigonelline [Color figure can be viewed at wileyonlinelibrary.com]
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Nevertheless, some analytes showed a remarkably lower recovery,
especially arginine and histidine compounds, but also citrulline and
hydroxyproline. This finding is consistent with a certain affinity to
plasma proteins, which seems to be more relevant for compounds
bearing more than one basic nitrogen. For instance, it is known that
ADMA shows low hemodialysis efficiency, pointing to the significant
plasma binding which was estimated to 30–90%.49,50 However, one
has to keep in mind that the current protocol is intended for analysis
of the accessible fraction rather than the tightly-bound analyte pool,
thus covering mainly free amino compounds. Access to the complete
tightly bound analyte pool would require significantly altered sample
preparation, which was beyond the scope of the present method.
Consequently, estimates of true control values have to be taken with
caution, considering that a certain fraction of the spike may be tightly
bound. Nevertheless, this is rather a problem of correct calculation of
reference values than of the analysis accuracy itself. Moreover, all
affected analytes show high precision, albeit at the lower
concentration of the accessible analyte fraction.
Stability was tested using different conditions, as depicted in
section 2. Most compounds are quite stable, and the observed
deviations were usually <15% and rather reflect the uncertainty of
the method than the instability of the analyte.
3.3 | Analysis of KarMeN study samples and
associations with current food consumption
In order to prove the suitability of the method for real-life study
samples, urine samples from KarMeN were analyzed. Results of partial
Spearman's correlation analyses are given in File S1, supporting
information. The main results for the respective food groups are
shown in Figure 2.
One of the most frequently reported biomarkers for food
consumption is trigonelline, which is highly associated with coffee
consumption.6 This association was clearly confirmed by our data
(ρ = 0.76; p <0.0001).
A moderate association was also observed between stachydrine
(proline-betaine) and consumption of citrus fruits (ρ = 0.56;
p <0.0001) or citrus juice (ρ = 0.58; p <0.0001). This is also in
accordance with the literature.7 A weak association was also found
with the analogous compound betonicine (hydroxyproline-betaine).
Moreover, associations with citrus fruits and juices were found for N-
methylproline and (less pronounced) for proline, but not for
hydroxyproline. These results are in accordance with the fact that
hydroxyproline is a degradation-product of collagen,51,52 whereas the
other proline compounds are mainly present in varying amounts in
different fruits.
Another significant association was found between TMAO and
consumption of fish and seafood (ρ = 0.30; p = 0.0217). Interestingly,
association of fish consumption with the related compounds DMA
and TMA was negligible; it was not significant in our small study
group. Indeed, TMAO was proposed as a biomarker for fish
consumption previously.9-12 However, there is strong evidence that
the specificity of this marker is limited since TMAO is produced from
many sources, and food ingestion explains only a small part of TMAO
variation.34 Figure 2E shows the associations of various food groups
with urinary TMAO level. Fish clearly had the strongest association.
The influence of other food groups (including meat) was negligible,
F IGURE 2 Box plots of specific dietary intake
(percentiles) and urinary concentrations of related
metabolites: A, Coffee and trigonelline; B, citrus
fruits and stachydrine; C, meat and carnosine; D,
red or white meat and anserine; E, fish, meat or
dairy and TMAO
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with one exception: the association with milk was as strong as with
fish (ρ = 0.31; p = 0.0192), albeit with high variation. Interestingly, this
was observed for milk only, but not for cheese. Such differences
between various milk products have been discussed before, but
results were not clear.53-55 The present finding is in accordance with
recently published results from intervention studies with different
milk products.56-58
A number of analytes in our method have been related to
consumption of meat, some of them being specific for consumption
of red or white meat. In our subgroup, strong associations with total
meat consumption (meat and meat products including sausages) were
found especially for the dipeptide carnosine (ρ = 0.76; p <0.0001) and
for τ-N-methylhistidine (ρ = 0.66; p <0.0001). Interestingly,
associations with the analogous compounds anserine and π-N-
methylhistidine were much less pronounced. In contrast, anserine
(ρ = 0.63; p <0.0001) and π-N-methylhistidine (ρ = 0.54; p <0.0001)
were both highly specific for consumption of white meat, e.g. chicken,
whereas carnosine and τ-N-methylhistidine showed no specificity.
This is in accordance with the previous findings.11,13-17 Moreover, a
number of further analytes showed moderate associations with total
meat consumption, especially γ-butyrobetaine (ρ = 0.45; p = 0.0004),
but also carnitine. However, none of these compounds showed
specificity for red or white meat (File S1, supporting information).
It has to be noted that the KarMeN subset used for the present
investigation was not representative, which means that the strength
of the association cannot be generalized. However, the expected
associations between selected foods and certain analytes were clearly
detected with significant power. In summary, analysis of the KarMeN
urine samples showed that the method is suitable for use in human
studies, especially in the context of nutrition.
4 | CONCLUSIONS
The presented HILIC/MRM method is reasonably easy to apply and
allows monitoring of several amine compounds in biological fluids, all
of them being relevant in the context of nutrition, physical activity, or
health. Validation proved clearly that the method is suited for the
intended purpose. The precision, working range and LLOQ are
appropriate for using the method in nutrition studies, as exemplified
in a KarMeN subset. Already established associations of food
consumption with respective metabolites could be confirmed with
high confidence. The method has already been applied to a recent
study investigating the effect of high intensity training on the
metabolome48 and to two dairy intervention studies.56-58 Thus, the
method is fit-for-purpose, and will be used in upcoming studies.
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